Wird geladen...
OS06.2 Combination RNAi therapy against glioma stem cells via sustained lipopolymeric nanoparticle delivery delays tumor progression
Background: Glioma stem cells (GSCs) have been identified as the predominant contributor to the therapy resistance, recurrence, and progression of malignant glioma, particularly glioblastoma multiforme (GBM). However, GSCs are elusive therapeutic targets across the blood brain barrier, underscoring...
Gespeichert in:
| Veröffentlicht in: | Neuro Oncol |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5463699/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.036 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|